TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MDLK›Financials
Annual statements · SEC XBRL · FY2014 – FY2025

ModuLink Inc. (MDLK) financials

Income statement

ModuLink Inc. (MDLK) income statement, annual, from SEC filings
Fiscal yearFY2014FY2015FY2016FY2024FY2025
Revenue$30.0K$98.9K$60.5K$409K$1.29M
Revenue growth—229.8%-38.8%576.2%216.3%
Gross profit$30.0K$98.9K$60.5K$60.2K$67.8K
Gross margin100.0%100.0%100.0%14.7%5.2%
Operating income—-$72.0K-$12.3K-$239K-$1.24M
Operating margin—-72.8%-20.3%-58.3%-95.6%
Net income-$177K-$72.0K-$122K-$283K-$1.27M
Net margin-590.8%-72.8%-202.1%-69.2%-98.1%
EPS (diluted)$0.00$0.00—-$0.00-$0.00

Cash flow

ModuLink Inc. (MDLK) cash flow, annual, from SEC filings
Fiscal yearFY2014FY2015FY2016FY2024FY2025
Operating cash flow———-$345K-$1.24M
Capital expenditures———$25.7K$36.8K
Free cash flow———-$371K-$1.27M

Balance sheet

ModuLink Inc. (MDLK) balance sheet, annual, from SEC filings
Fiscal yearFY2014FY2015FY2016FY2024FY2025
Cash & equivalents$96.4K$9.00K$3.31K$382K$153K
Total assets$227K$159K$587K$1.06M$679K
Total liabilities—$3.20K$554K$905K$729K
Shareholders' equity$189K$156K$33.6K$151K-$49.9K
Retained earnings-$177K-$279K-$402K-$2.85M-$4.12M
Shares (wtd avg diluted)12.2M12.5M12.5M7.83B7.97B

Every figure is extracted from ModuLink Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is ModuLink Inc.'s annual revenue?
ModuLink Inc. (MDLK) reported $1.29M of revenue for fiscal year 2025 — up 216.3% from $409K in FY2024, per its annual report filed with the SEC.
Is ModuLink Inc. profitable?
Not in FY2025 — MDLK reported a net loss of $1.27M, per SEC filings.
What is ModuLink Inc.'s free cash flow?
-$1.27M in FY2025 (operating cash flow -$1.24M minus $36.8K of capital expenditures), from the SEC cash-flow statement.
Does MDLK pay a dividend?
ModuLink Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full MDLK analysis — verdict, score & filings →Is MDLK a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.